Lung cancer patients with an abnormal gene benefit from targeted therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|20|3582-3582

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.20, 2013-10, pp. : 3582-3582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapy in lung cancer: Survival, quality of life improved for some patients

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2625-2626

John Wiley & Sons Inc

Access to resources Recommend Favorite

Concomitant Chemoradiotherapy and Antiretroviral Therapy for HIV-Infected Patients with Locoregionally Advanced Non-Small Cell Lung Cancer: Benefit and Tolerability of Treatment in 2 Cases

By  

Oncology Research and Treatment, Vol. 36, Iss. 10, 2013-09 ,pp. : 586-590

Karger

Access to resources Recommend Favorite

Are There Breast Cancer Patients with Node-Negative Small Tumours, Who Do Not Benefit from Adjuvant Systemic Therapy?

By  

Oncology, Vol. 92, Iss. 6, 2017-03 ,pp. : 317-324

Karger

Access to resources Recommend Favorite

Immunochemistry and Lung Cancer: Application in Diagnosis, Prognosis and Targeted Therapy

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 247-256

Karger

Access to resources Recommend Favorite

Targeted therapy in gastric cancer

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 5, 2015-05 ,pp. : 365-372

John Wiley & Sons Inc

Access to resources Recommend Favorite